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Abstract
In response to different stress stimuli, cells transiently form stress granules (SGs) in order
to protect themselves and re-establish homeostasis. Besides these important cellular
functions, SGs are now being implicated in different human diseases, such as neu-
rodegenerative disorders and cancer. SGs are ribonucleoprotein granules, constituted
by a variety of different types of proteins, RNAs, factors involved in translation and
signaling molecules, being capable of regulating mRNA translation to facilitate stress
response. However, until now a complete list of the SG components has not been
available. Therefore, we aimer at identifying and linting in an open access database all
the proteins described so far as components of SGs. The identification was made through
an exhaustive search of studies listed in PubMed and double checked. Moreover, for each
identified protein several details were also gathered from public databases, such as the
molecular function, the cell types in which they were detected, the type of stress stimuli
used to induce SG formation and the reference of the study describing the recruitment of
the component to SGs. Expression levels in the context of different neurodegenerative
diseases were also obtained and are also described in the database. The Mammalian
Stress Granules Proteome is available at https://msgp.pt/, being a new and unique open
access online database, the first to list all the protein components of the SGs identified
so far. The database constitutes an important and valuable tool for researchers in this
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Introduction
Cells are exposed to different stress stimuli that they need
to overcome ensuring cell survival. To manage stress, cells
have several mechanisms ranging from repair pathways to
apoptosis triggering, if cells fail to overcome the stress.
Growing evidence suggests that a persistent cellular stress
state might underlie an enhanced susceptibility to aging or
aging-related diseases, like neurodegenerative disorders or
cancer (1).
The assembly of stress granules (SGs) represents a con-
servative component of the cellular response to stress. SGs
are ribonucleoprotein granules that appear when eukary-
otic cells are exposed to certain types of stimuli such as
endoplasmic reticulum stress, heat shock, hypoxia, arsenite,
viral infection or overexpression of specific RNA-binding
proteins (RBPs) (2). SGs are transiently formed upon cel-
lular stress, and their disassembly occurs when the cellular
stressor is removed. The canonical SG assembly pathway is
triggered by the phosphorylation of eIF2α leading to the
inhibition of translation, and thereby creating a pool of
mRNAs stalled in translation initiation, translation initia-
tion factors, RBPs and ribosomal units (3). SG assembly is
key to cell survival as these foci inhibit apoptosis through
reduction of reactive oxygen species (ROS), sequestration
of signaling molecules and stabilization of mRNAs of anti-
apoptotic factors (4). Under stress conditions, global trans-
lation is reduced, and SGs are thought to function in the
triage of repressed mRNAs, allowing a focused translation
of proteins critical to overcome stress (5). Additionally,
stalled mRNAs in SGs are protected from degradation
during stress and can rapidly re-enter the translational
pool once stress is overcome and they are released (6).
Despite these important functions in translation and several
others described, the complete functions of SGs are not yet
understood.
The molecular composition of SG core is based
in stalled mRNA transcripts, poly(A) mRNAs, RBPs,
translation initiation factors, proteins with predicted low-
complexity domains and small (40S) ribosomal units (7).
Due to their frequent presence in SGs, some proteins, are
commonly used as SG markers, including several eukaryotic
initiation factors, poly(A)-binding protein 1 (PABP1), T-
cell intracellular antigen 1 (TIA-1), TIA-1-related protein
(TIAR), Ras GTPase-activating protein-binding protein 1
(G3BP1) and ataxin-2 (8). Nevertheless, SG composition
changes during the stress response and is also different
according to the type of stress or cell (9). In fact, recently,
it was found that ∼20% of SG components diversity is
dependent on the stress and the cell type (10).
Growing and recent evidence implicates SGs in the
context of human disease, namely in cancer (2) and in neu-
rodegenerative disorders (11). For example, in cancer, SGs
were found in different tumors with different histological
origins (12–14). In the same line, in Alzheimer’s disease
(AD) several SG components accumulate in affected
cells and colocalize with pathogenic tau (15, 16). We also
showed that, in the context of another neurodegenerative
disease - Machado–Joseph, the SG component ataxin-2 is
downregulated, contributing decisively to the pathology,
whereas its overexpression ameliorates the disease pheno-
type (17). On the other hand, antisense oligonucleotides-
mediated ATXN2 silencing was successful in reducing
neuropathological abnormalities in spinocerebellar ataxia
type 2 and amyotrophic lateral sclerosis animal models
(18, 19). Additionally, SGs could also be implicated in the
normal aging process, as a reduction in the expression of
several SG components with age, especially RBPs, has been
described (20).
A database consists in a storage of information that
can be easily accessed and that is regularly managed and
updated. Therefore, databases serve as an important tool
for research and, accordingly, the number of databases has
been increasing in the past years (21). Despite the growing
interest in SG research and several reviews on the topic,
there is still a lack of resources for their study. There are
several important databases on RBPs, focusing on different
aspects of their structure or function, although they do not
address the RBPs’ role/presence in SGs (22, 23). SGs were
originally described in tomato cell lines submitted to heat
shock (24), and since then several studies demonstrated the
recruitment of different proteins to SGs. However, the com-
plete list of SG components is unknown. Thus, we generated
electronic resources in the form of Excel-based databases/
tables containing all the protein components recruited to
SGs that have been described so far. These data were the
basis for the development of an online database available
at https://msgp.pt/, which we now present. The database
curates general information about all the protein compo-
nents of SGs described so far in mammalian cells. The
platform provides a new and unique resource for the SG
research field, collecting and storing for the first time and
in the same place all the information on the SG protein
components.
Material and methods
Components identification and curation
We curated the published literature available in different
databases (like for example PubMed) covering all the SG
protein components described in studies using mammalian
cells. Several keyword combinations were used, such as
stress granules AND mammals or stress granules AND
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different proteins to SGs was double checked, and the type
of cell, stimulus used and effective recruitment of the com-
ponent to the SGs were annotated and confirmed. Addition-
ally, for all the identified and validated SG components sev-
eral details were gathered from public databases, including
the protein abbreviation, gene ID, chromosomal location,
Uniprot ID, molecular function, subcellular localization,
original study describing its recruitment to SGs (along
with the cell type and stimulus used), RBP classification
[according to (25)], identity as autophagy-related proteins
[according to (26)] and the OMIM details for their possible
implication in human genetic disorders. All these details
were gathered in the form of Excel-based databases/tables.
Gene expression data analysis
The GEO Expression Omnibus public database was used
to find studies describing gene expression data in different
neurodegenerative diseases. From the found studies, three
were chosen based on the high number of sampled individ-
uals, as well as on the type of neurodegenerative disease
studied.
Expression profiles for all the identified and curated
SG components were extracted from a transcriptome data
set of human brain biopsy tissue sample, covering sub-
jects with AD, Huntington’s disease (HD) and healthy con-
trols [GSE33000; (27)]; subjects with Parkinson’s disease
(PD) and healthy controls (GSE28894); and subjects with
amyotrophic lateral sclerosis (ALS) and healthy controls
[GSE4595; (28)]. We analyzed the original expression data
using the Geo2R web tool (http://www.ncbi.nlm.nih.gov/
geo/geo2r/) comparing the different groups: AD versus
controls, HD versus controls, PD versus controls and ALS
versus controls. An adjusted P < 0.05 accessed the SG
components whose expression was statistically different
between groups. Adjustments were made to correct the
occurrence of false positive results, using the Benjamini and
Hochberg false discovery rate method.
Software tools and database implementation
The Mammalian Stress Granules Proteome (MSGP) is an
online and open access database. The website was imple-
mented using the Wordpress system, and the database was
build using ‘custom fields’, based on the open source tool
‘Elementor Page Builder’. The database includes, also, other
important features like custom listing profile for each pro-
tein, custom fields with editing capability for each protein,
highly customized GeneID cards, protein listing quick view,
breadcrumbs navigation, custom dashboard for front and
end users and customized and multiple IDs for each protein.
We also included >50 widgets ready to use on the database
(keeping in mind its future expansion), integrated in a clean
system, compatible with PHP version 5.5+, and we used
minified and combined assets to reduce the amount of http
requests and enhance load time and site performance. The
system was built using Vue.js JavaScript framework and we
programmed clean and well-structured code, to facilitate
access to the data. The MSGP platform was also conceived
to be responsive, working on all types of devices (mobile
phones, tablets, computers etc.) and integrating the future
functionality of user sign in/registration.
Results
Database structure
The MSGP database was developed in a highly customized
way, allowing the introduction of several important features
and future uses. The structure and navigation were planned
to work in a very intuitive and user-friendly manner. More-
over, a ‘How to use’ section where database users can find
a tutorial showing the search process as well as the system
navigation, especially in each SG component-specific page,
was also created. The MSGP database contains primarily
the 464 proteins identified as components of the SGs, which
can be retrieved through different pages from the database
website or from a general search. The structure of the
database is described in Figure 1, providing three major
sections: All proteins, grouping the information and details
on the 464 proteins identified; the RBP section, where all
SG components classified as RBPs are grouped; and the
Autophagy section, where all SG components that belong
to the autophagy pathway are grouped. Additionally, the
database has a page ‘Protein Index’ where all the SG compo-
nents are listed alphabetically. The database allows further
exploring of the identified and curated components, in the
‘Featured Proteins’ section or in the ‘New Proteins’ section,
where the proteins most recently included in the database
are added. Furthermore, the database allows exploring the
listed proteins according to different tags, such as sodium
arsenite, U-2 OS or Hela cells.
Database content
For each one of the 464 identified proteins a set of details
can also be found, including for example its molecular
function, the complete protein name or its subcellular local-
ization. Moreover, in each component we detail the original
study describing its recruitment to SGs, as well as the type
of stimulus used to induce SG assembly and the type of cell
employed in that study. Due to the importance of RBPs to
the nucleation and formation of SGs we also detail if the
identified component is an RBP or not. Interestingly and
as expected, from the 464 proteins identified 252 (54%)
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Figure 1. Structure of the MSGP database, depicting the main sections, different filters, tags and forms to explore and retrieve the information stored
in the database.
Figure 2. Molecular function of the 464 proteins currently identified as
components of mammalian SGs, according to a gene list analysis by
the PANTHER classification system.
study and to the Uniprot database. In line with this data,
we performed a molecular function analysis of the 464 SG
components (using the Protein Analysis Through Evolu-
tionary Relationships available at http://www.pantherdb.
org), which revealed that majority of the identified proteins
have a binding or catalytic activity (Figure 2).
Online interface
The online interface of the MSGP database homepage has a
‘Search’ form and three main tabs, ‘All Proteins’, ‘RBP’ and
‘Autophagy’ (Figure 3A). The ‘Search’ form allows a free
text exploration of possible components of the database;
the tab ‘All proteins’ lists all the proteins listed in the
database; the tab ‘RBP’ lists the proteins classified in the
database as RBPs; the tab ‘Autophagy’ groups all the pro-
teins involved in this pathway (26) that are recruited to SGs.
In the search form, four categories can be selected: (i) All
Proteins, (ii) RBP, (iii) OMIM disease and (iv) Autophagy
(Figure 3B). The first option allows a search in the entire
database, whereas the three other options narrow the search
to the SG components that are RBPs, linked to a human
disease or to autophagy, respectively. The database landing
page also has additional filters and tags that can be used
to refine the listed proteins in the database (Figure 3C).
For example, the ‘U-2 OS cells’ tab at the end of the page
groups the SG components that were identified in these
cells. As already mentioned, all the proteins in the database
are listed in alphabetical order in the page ‘Protein Index’
to facilitate the search and to collect in the same page all
the components of the SGs in the database (Figure 3A).
Searching and search results
The components listed in the database can be searched
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Figure 3. (A) The online interface of the database, detailing the landing page with the search form and the different pages. (B) The different options
to narrow the search. (C) The possibility of accessing the listed components through different tags.
be found in databases such as Uniprot or GeneCards. For
example, for the core SG component GTPase-activating
protein (SH3 domain) binding protein 1 the search should
be performed using the alias ‘G3BP1’. If no selection is
made, the search is performed in the ‘All Proteins’ category
(Figure 3B). Each component must be searched alone, as
the use of ‘AND’, ‘OR’ and ‘NOT’ is not recognized by the
database. If several SG components are listed with similar
names, as in case as they belong for example to the same
family, the search will list all those proteins. For example,
the search for ‘PABP’ in the database will result in three hits:
PABP1, PABP3 and PABP4.
Specific component pages
Each protein listed as a SG component in the MSGP
database has a specific page where the different information
details are listed. Independently from the form used to
find a specific protein in the database (search, tabs, filters,
index or general sections), the individual page for each
protein is the same (Figure 4A). The complete name of
the protein, the gene and Uniprot IDs, the chromosomal
location, RBP classification (yes or no), the molecular
function, OMIM details and subcellular localization are
detailed for each component (Figure 4B). Each page
also describes the category/categories where that specific
component was classified (Figure 4C). Importantly, the
original study describing the recruitment of that protein
to SGs is referred, as well as the type of stimulus used to
induce SGs assembly and the type of cell used in the study.
In each SG component page it is also possible to find the
gene expression values for that component in the context
of different neurodegenerative diseases (Figure 4D).
Expression data
The expression data for each of the SG components
listed was extracted from different published studies and
available in open access databases. The analysis compared
the expression levels in patients with different neurode-
generative diseases and healthy controls. The differential
expression level for each SG component in the different
neurodegenerative diseases was plotted into a graphic and
is also a part of the component-specific page (Figure 4D). As
mentioned, several studies implicate SGs in different neu-
rodegenerative diseases. Moreover, most of SG components
are RBPs, which in the context of neurons are involved in
different processes such as alternative splicing, transport,
localization and stability and translation of RNAs (29).
Thus, alterations in their expression may underlie or
have impact on the neurodegenerative pathogenesis. In
fact, the analysis of the differential expression of the 464
SG components detected that 380 components have the
expression altered in the brain of AD patients (Figure 5A).
Similarly, in the brain of HD patients, 395 have their
expression significantly altered. From these, 191 SG
components have their expression commonly altered in
AD and HD, with 90 having the expression increased and
101 repressed (Figure 5B).
Users interaction and future updates
At the moment the database does not have a page for
users to submit new SG components; however, researchers
could send that information to the contacts in the database
and shortly it will be updated. Nevertheless, there will be
a continuous updating for new SG components from the
published studies indexed in PubMed. The entire data set
of the database is also available for any researcher upon
request by email to cdnobrega@ualg.pt. The future plans
for updating the database include adding information on
the gene expression levels of SG components for different
types of cancer. Importantly, we will continue to complete
each protein details with relevant information, especially
SG-related, as for example the number of studies where
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Figure 4. (A) Information details described in the specific page for the SG component TIAR, including a brief description of its molecular function.
(B) Several details for the component are listed in the database, including the study describing the recruitment of this protein to SGs. (C) Each SG
components is also included in specific categories, which are also displayed in its specific page. (D) For each SG component its expression levels in
the context of neurodegenerative diseases are also described in the form of a graph, based on a differential expression analysis.
Figure 5. (A) SG components whose expression is significantly altered
in the brain of AD and HD patients and commonly in both diseases. (B)
Details on the number of SGs protein components whose expression is
significantly induced or repressed in each disease and in both diseases.
to include other SG components besides proteins, such as
miRNAs or mRNAs.
Conclusions
The MSGP database is the first tool cataloging all the
SGs’ protein components described so far. Moreover, it
also collects several details about each component, thus
providing an important tool for researchers in this area.
The growing interest in the SG field and their implication
in different human diseases make this database actual and
opportune. Furthermore, the MSGP database has the pos-
sibility of being continuously updated as more components
are described in SGs, and also of being expanded by adding
more information and details, for example detailing the
expression levels of these components in the context of
different types of cancer. The database will constitute an
important asset for SG research and will be continuously
improved, based on our already defined plans and on the
feedback from users.
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1. Poljšak,B. and Milisav,I. (2012) Clinical implications of cellular
stress responses. Bosn. J. Basic Med. Sci., 12, 122–126.
2. Anderson,P., Kedersha,N. and Ivanov,P. (2015) Stress granules,
P-bodies and cancer. Biochim. Biophys. Acta, 1849, 861–870.
3. Thomas,M.G., Loschi,M., Desbats,M.A. et al. (2011) RNA gran-









 Portugal user on 08 July 2019
Database, Vol. 2019, Article ID baz031 Page 7 of 7
4. Gareau,C., Fournier,M.J., Filion,C. et al. (2011)
p21(WAF1/CIP1) upregulation through the stress granule-
associated protein CUGBP1 confers resistance to bortezomib-
mediated apoptosis. PLoS One, 6, e20254.
5. Anderson,P. and Kedersha,N. (2006) RNA granules. J. Cell Biol.,
172, 803–808.
6. Chantarachot,T. and Bailey-Serres,J. (2018) Polysomes, stress
granules, and processing bodies: a dynamic triumvirate control-
ling cytoplasmic mRNA fate and function. Plant Physiol., 176,
254–269.
7. Khong,A., Matheny,T., Jain,S. et al. (2017) The stress granule
transcriptome reveals principles of mRNA accumulation in
stress granules. Mol. Cell, 68, 808–820 e805.
8. Carmo-Silva,S., Nobrega,C., Pereira de Almeida,L. et al.
(2017) Unraveling the role of ataxin-2 in metabolism. Trends
Endocrinol. Metab., 28, 309–318.
9. Vanderweyde,T., Youmans,K., Liu-Yesucevitz,L. et al. (2013)
Role of stress granules and RNA-binding proteins in neurode-
generation: a mini-review. Gerontology, 59, 524–533.
10. Markmiller,S., Soltanieh,S., Server,K.L. et al. (2018) Context-
dependent and disease-specific diversity in protein interactions
within stress granules. Cell, 172, 590–604.
11. Wolozin,B. (2012) Regulated protein aggregation: stress gran-
ules and neurodegeneration. Mol. Neurodegener., 7, 56.
12. Vilas-Boas Fde,A., da Silva,A.M., de Sousa,L.P. et al. (2016)
Impairment of stress granule assembly via inhibition of the
eIF2alpha phosphorylation sensitizes glioma cells to chemother-
apeutic agents. J. Neurooncol., 127, 253–260.
13. Adjibade,P., St-Sauveur,V.G., Quevillon Huberdeau,M. et al.
(2015) Sorafenib, a multikinase inhibitor, induces formation
of stress granules in hepatocarcinoma cells. Oncotarget, 6,
43927–43943.
14. Somasekharan,S.P., El-Naggar,A., Leprivier,G. et al. (2015) YB-
1 regulates stress granule formation and tumor progression by
translationally activating G3BP1. J. Cell Biol., 208, 913–929.
15. Vanderweyde,T., Yu,H., Varnum,M. et al. (2012) Contrasting
pathology of the stress granule proteins TIA-1 and G3BP in
tauopathies. J. Neurosci., 32, 8270–8283.
16. Ash,P.E., Vanderweyde,T.E., Youmans,K.L. et al. (2014) Patho-
logical stress granules in Alzheimer’s disease. Brain Res., 1584,
52–58.
17. Nóbrega,C., Carmo-Silva,S., Albuquerque,D. et al. (2015) Re-
establishing ataxin-2 downregulates translation of mutant
ataxin-3 and alleviates Machado–Joseph disease. Brain, 138,
3537–3554.
18. Scoles,D.R., Meera,P., Schneider,M.D. et al. (2017) Antisense
oligonucleotide therapy for spinocerebellar ataxia type 2.
Nature, 544, 362–366.
19. Becker,L.A., Huang,B., Bieri,G. et al. (2017) Therapeutic reduc-
tion of ataxin-2 extends lifespan and reduces pathology in TDP-
43 mice. Nature, 544, 367–371.
20. Masuda,K., Marasa,B., Martindale,J.L. et al. (2009) Tissue-
and age-dependent expression of RNA-binding proteins that
influence mRNA turnover and translation. Aging (Albany NY),
1, 681–698.
21. Curbelo,R.J., Loza,E., de Yébenes,M.J. et al. (2014) Databases
and registers: useful tools for research, no studies. Rheumatol.
Int., 34, 447–452.
22. Giudice,G., Sanchez-Cabo,F., Torroja,C. et al. (2016)
ATtRACT—a database of RNA-binding proteins and associated
motifs. Database (Oxford), 2016.
23. Cook,K.B., Kazan,H., Zuberi,K. et al. (2011) RBPDB: a
database of RNA-binding specificities. Nucleic Acids Res., 39,
D301–D308.
24. Nover,L., Scharf,K.D. and Neumann,D. (1983) Formation of
cytoplasmic heat shock granules in tomato cell cultures and
leaves. Mol. Cell. Biol., 3, 1648–1655.
25. Castello,A., Fischer,B., Eichelbaum,K. et al. (2012) Insights into
RNA biology from an atlas of mammalian mRNA-binding
proteins. Cell, 149, 1393–1406.
26. Homma,K., Suzuki,K. and Sugawara,H. (2011) The autophagy
database: an all-inclusive information resource on autophagy
that provides nourishment for research. Nucleic Acids Res., 39,
D986–D990.
27. Narayanan,M., Huynh,J.L., Wang,K. et al. (2014) Common
dysregulation network in the human prefrontal cortex underlies
two neurodegenerative diseases. Mol. Syst. Biol., 10, 743.
28. Lederer,C.W., Torrisi,A., Pantelidou,M. et al. (2007) Pathways
and genes differentially expressed in the motor cortex of patients
with sporadic amyotrophic lateral sclerosis. BMC Genomics,
8, 26.
29. Bryant,C.D. and Yazdani,N. (2016) RNA-binding proteins, neu-










 Portugal user on 08 July 2019
